Author:
Bressler Neil M.,Varma Rohit,Suñer Ivan J.,Dolan Chantal M.,Ward James,Ehrlich Jason S.,Colman Shoshana,Turpcu Adam
Reference18 articles.
1. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2010
2. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema;Mitchell;Ophthalmology,2011
3. Ohji M, Ishibashi T. Efficacy and safety of ranibizumab 0.5 mg as monotherapy or adjunctive to laser versus laser monotherapy in Asian patients with visual impairment due to diabetic macular edema: 12-month results of the REVEAL study. [ARVO abstract 4664]. Available at http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=33d868e0-ab8d-406c-b25e-15fff568bf34&cKey=4a8712da-de4e-4f18-a3ad-6140801095c7&mKey=f0fce029-9bf8-4e7c-b48e-9ff7711d4a0e. Accessed on December 18, 2013.
4. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE;Nguyen;Ophthalmology,2012
5. Mangione CM. The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25). Version 2000. Available at: http://www.nei.nih.gov/resources/visionfunction/vfq_ia.pdf Accessed May 7, 2012.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献